Find insight on Fresnillo, the copper market, Australian mining, and more in the latest Market Talks covering Basic Materials ...

High-rolling investors have positioned themselves bullish on Biogen BIIB, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of ...

Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced that Chief Executive Officer Marc Viscogliosi ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Canaccord raised the firm’s price target on Okta (OKTA) to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported ...

Morgan Stanley reaffirmed Tesla as its top pick, maintaining a $430 price target despite mixed analyst ratings. Some firms, ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

Salesforce’s Q1 2026 earnings are forecasted at $1.86 per share, according to DA Davidson. The firm maintained a "Neutral" ...

While many of its peers abandon the lithium sector, Green Technology Metals is priming itself for development.

We recently compiled a list of the Wall Street Optimism Spills Over to These 10 Stocks on Friday. In this article, we are ...

Bank of Montreal (TSE:BMO – Free Report) (NYSE:BMO) had its price target increased by Canaccord Genuity Group from C$154.00 ...

Shares of DoubleVerify touched a record low after its full-year outlook missed Wall Street estimates, its fourth-quarter revenue came in lower than expected and two firms cut their target prices.